SLG
62
-4
DIS
62
2
MRO
46
3
C
62
-3
XEL
65
-2
AAPL
45
3
CMI
67
4
DVA
72
-3
AA
38
-2
EW
32
3
EMR
77
-2
PAYX
57
-2
SYY
47
-2
GLW
48
-5
XRX
34
-3
DUK
50
-2
CTSH
65
-3
SCHW
65
-2
FOX
57
-3
EFX
41
-2
SLG
62
-4
DIS
62
2
MRO
46
3
C
62
-3
XEL
65
-2
AAPL
45
3
CMI
67
4
DVA
72
-3
AA
38
-2
EW
32
3
EMR
77
-2
PAYX
57
-2
SYY
47
-2
GLW
48
-5
XRX
34
-3
DUK
50
-2
CTSH
65
-3
SCHW
65
-2
FOX
57
-3
EFX
41
-2
Financhill
Back

Aligos Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
67

ALGS
Aligos Therapeutics

Last Price:
19.46
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Aligos Therapeutics Price Quote

$19.46

Aligos Therapeutics Key Stats

Buy
67
Aligos Therapeutics (ALGS) is a Buy
Day range:
$15.66 - $20.44
52-week range:
$6.76 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.68
P/B ratio:
1.39%
Volume:
625K
Avg. volume:
318.3K
1-year change:
31.49%
Market cap:
$69.8M
Revenue:
$15.5M
EPS:
$-17.11

How Much Does Aligos Therapeutics Make?

Is Aligos Therapeutics Growing As A Company?

  • What Is Aligos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.61%
  • What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Aligos Therapeutics Stock Price Performance

What Is Aligos Therapeutics 52-Week High & Low?

Aligos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aligos Therapeutics?

Is Aligos Therapeutics Cash Flow Positive?

  • What Is ALGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85M
  • What Is Aligos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $88.2M
  • What Is Aligos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$38.3M

Aligos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ALGS return on invested capital is -118.75%
  • What Is Aligos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -68.4%
  • What Is ALGS Return On Equity?
    ROE is a measure of profitability and is -118.75%

Aligos Therapeutics Earnings Date & Stock Price

Aligos Therapeutics Competitors

Aligos Therapeutics Dividend Yield

Aligos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -131.7%
Revenue: -60.82% 280.7%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 103.33
Upside from Last Price: 431%

Major Shareholders

  • How many ALGS shares are owned by institutional investors?
    57.5M ALGS shares are owned by institutional investors
  • How many ALGS shares are owned by insiders?
    0 ALGS shares are owned by insiders